Background - Objectives: Mangiferin, a polyphenol compound, has been reported to possess several bioactivities including the herpes simplex virus treatment. In order to develop an effective anti-herpes simplex virus product for vaginal administration, the in situ gel formulation containing mangiferin-loaded nanostructured lipid carriers (inMGF-NLC) was developed.